Mhd Wasem Alsabbagh

661 total citations
39 papers, 453 citations indexed

About

Mhd Wasem Alsabbagh is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Economics and Econometrics. According to data from OpenAlex, Mhd Wasem Alsabbagh has authored 39 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Economics and Econometrics. Recurrent topics in Mhd Wasem Alsabbagh's work include Medication Adherence and Compliance (6 papers), Influenza Virus Research Studies (5 papers) and Diabetes Treatment and Management (5 papers). Mhd Wasem Alsabbagh is often cited by papers focused on Medication Adherence and Compliance (6 papers), Influenza Virus Research Studies (5 papers) and Diabetes Treatment and Management (5 papers). Mhd Wasem Alsabbagh collaborates with scholars based in Canada, United Kingdom and United States. Mhd Wasem Alsabbagh's co-authors include Mark Lemstra, Dean T. Eurich, David Blackburn, Lalitha Raman‐Wilms, Thomas W. Wilson, Lisa M. Lix, Sherilyn K. D. Houle, Barbara Farrell, James Conklin and Kelly Grindrod and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medical Care and Addiction.

In The Last Decade

Mhd Wasem Alsabbagh

35 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mhd Wasem Alsabbagh Canada 12 127 112 109 97 77 39 453
Luíz Miguel Santiago Portugal 11 111 0.9× 83 0.7× 72 0.7× 138 1.4× 153 2.0× 102 517
Nico Gabriel United States 9 142 1.1× 60 0.5× 44 0.4× 129 1.3× 97 1.3× 41 526
Phantipa Sakthong Thailand 12 172 1.4× 54 0.5× 143 1.3× 236 2.4× 89 1.2× 35 546
Nicky Richards United Kingdom 7 153 1.2× 188 1.7× 51 0.5× 133 1.4× 73 0.9× 9 491
Janaka Lovell Australia 8 162 1.3× 90 0.8× 83 0.8× 45 0.5× 110 1.4× 13 494
Adriana Dornelles United States 13 59 0.5× 138 1.2× 118 1.1× 48 0.5× 51 0.7× 27 492
Roland Rapold Switzerland 13 221 1.7× 61 0.5× 138 1.3× 201 2.1× 158 2.1× 23 639
Deborah McCahon United Kingdom 14 104 0.8× 257 2.3× 34 0.3× 109 1.1× 111 1.4× 33 650
S. Dee Melnyk United States 11 142 1.1× 222 2.0× 208 1.9× 103 1.1× 122 1.6× 16 489
Gebre Teklemariam Demoz Ethiopia 13 52 0.4× 71 0.6× 76 0.7× 56 0.6× 38 0.5× 27 546

Countries citing papers authored by Mhd Wasem Alsabbagh

Since Specialization
Citations

This map shows the geographic impact of Mhd Wasem Alsabbagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mhd Wasem Alsabbagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mhd Wasem Alsabbagh more than expected).

Fields of papers citing papers by Mhd Wasem Alsabbagh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mhd Wasem Alsabbagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mhd Wasem Alsabbagh. The network helps show where Mhd Wasem Alsabbagh may publish in the future.

Co-authorship network of co-authors of Mhd Wasem Alsabbagh

This figure shows the co-authorship network connecting the top 25 collaborators of Mhd Wasem Alsabbagh. A scholar is included among the top collaborators of Mhd Wasem Alsabbagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mhd Wasem Alsabbagh. Mhd Wasem Alsabbagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Edginton, Andrea N., et al.. (2024). Health utilities in adults with hemophilia A: A retrospective cohort study. Haemophilia. 30(3). 733–742. 2 indexed citations
3.
Alkabbani, Wajd, Baiju R. Shah, Arsène Zongo, et al.. (2023). Post‐initiation predictors of discontinuation of the sodium‐glucose cotransporter‐2 inhibitors: A comparative cohort study from the United Kingdom. Diabetes Obesity and Metabolism. 25(12). 3490–3500. 5 indexed citations
4.
Cho, Hanna, Sherilyn K. D. Houle, & Mhd Wasem Alsabbagh. (2023). The trends and determinants of seasonal influenza vaccination after cardiovascular events in Canada: a repeated, pan-Canadian, cross-sectional study. Health Promotion and Chronic Disease Prevention in Canada. 43(2). 87–97. 5 indexed citations
5.
Houle, Sherilyn K. D., Mhd Wasem Alsabbagh, & Nancy M. Waite. (2023). Herpes zoster and human papillomavirus vaccination opportunities identified using electronic prompts at the time of scheduling influenza or COVID-19 vaccines. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 156(5). 257–264.
6.
7.
Alkabbani, Wajd, Arsène Zongo, Jasjeet K. Minhas‐Sandhu, et al.. (2021). Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score–matched Population-based Cohort Study. Canadian Journal of Diabetes. 46(4). 392–403.e13. 18 indexed citations
8.
Kim, John J., et al.. (2021). Economic evaluation of pharmacists prescribing for minor ailments in Ontario, Canada: a cost-minimization analysis. International Journal of Pharmacy Practice. 29(3). 228–234. 8 indexed citations
9.
Alkabbani, Wajd, John‐Michael Gamble, Dean T. Eurich, et al.. (2021). Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs. Diabetes & Metabolism. 48(2). 101305–101305. 4 indexed citations
10.
Alsabbagh, Mhd Wasem, et al.. (2020). Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias – A narrative review. Pharmacology Research & Perspectives. 8(4). e00622–e00622. 8 indexed citations
11.
Grindrod, Kelly, et al.. (2020). The Impact of Prescription Medication Cost Coverage on Oral Medication Use for Hypertension and Type 2 Diabetes Mellitus. Healthcare policy. 16(2). 82–100. 2 indexed citations
12.
Alsabbagh, Mhd Wasem, Sherilyn K. D. Houle, & Nancy M. Waite. (2019). The availability of pharmacists with Additional Prescribing Authorization in relation to the distribution of vulnerable populations - A cross-sectional study. Research in Social and Administrative Pharmacy. 16(1). 84–89. 4 indexed citations
13.
Alsabbagh, Mhd Wasem, et al.. (2018). Pharmacy patron perspectives of community pharmacist administered influenza vaccinations. Research in Social and Administrative Pharmacy. 15(2). 202–206. 12 indexed citations
14.
Alsabbagh, Mhd Wasem & Sherilyn K. D. Houle. (2018). The proportion, conditions, and predictors of emergency department visits that can be potentially managed by pharmacists with expanded scope of practice. Research in Social and Administrative Pharmacy. 15(11). 1289–1297. 11 indexed citations
15.
Farrell, Barbara, et al.. (2017). Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines. Research in Social and Administrative Pharmacy. 14(1). 18–25. 79 indexed citations
16.
Alsabbagh, Mhd Wasem, Kerry Mansell, Lisa M. Lix, et al.. (2015). Trends in Prevalence, Incidence and Pharmacologic Management of Diabetes Mellitus Among Seniors Newly Admitted to Long-Term Care Facilities in Saskatchewan between 2003 and 2011. Canadian Journal of Diabetes. 39(2). 138–145. 9 indexed citations
17.
Alsabbagh, Mhd Wasem, Mark Lemstra, Dean T. Eurich, et al.. (2014). Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis. Value in Health. 17(2). 288–296. 63 indexed citations
18.
Lemstra, Mark & Mhd Wasem Alsabbagh. (2014). Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis. Patient Preference and Adherence. 8. 211–211. 50 indexed citations
19.
Alsabbagh, Mhd Wasem, Lin Yan, Xinya Lu, et al.. (2013). Use and Misuse of Ezetimibe: Analysis of Use and Cost in Saskatchewan, a Canadian Jurisdiction With Broad Access. Canadian Journal of Cardiology. 30(2). 237–243. 2 indexed citations
20.
Alsabbagh, Mhd Wasem, Mark Lemstra, Dean T. Eurich, et al.. (2012). Pharmacist Intervention in Cardiac Rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention. 32(6). 394–399. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luíz Miguel Santiago Breakdown of academic impact, for papers by Nico Gabriel Breakdown of academic impact, for papers by Phantipa Sakthong Breakdown of academic impact, for papers by Nicky Richards Breakdown of academic impact, for papers by Janaka Lovell Breakdown of academic impact, for papers by Adriana Dornelles Breakdown of academic impact, for papers by Roland Rapold Breakdown of academic impact, for papers by Deborah McCahon Breakdown of academic impact, for papers by S. Dee Melnyk Breakdown of academic impact, for papers by Gebre Teklemariam Demoz
Rankless by CCL
2026